Gene · 9112
Papers2,013
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,013
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gnetin C Intercepts MTA1-Associated Neoplastic Progression in Prostate Cancer. | Cancers (Basel) | 2022 | 36551523 | PubTator, text mining | PubMed |
| Application of Extracellular Vesicles in Gynecologic Cancer Treatment. | Bioengineering (Basel) | 2022 | 36550946 | PubTator, text mining | PubMed |
| Natural Products as Anticancer Agents: Current Status and Future Perspectives. | Molecules | 2022 | 36500466 | PubTator, text mining | PubMed |
| Multi-Omics Immune Interaction Networks in Lung Cancer Tumorigenesis, Proliferation, and Survival. | Int J Mol Sci | 2022 | 36499305 | PubTator, text mining | PubMed |
| New Visions on Natural Products and Cancer Therapy: Autophagy and Related Regulatory Pathways. | Cancers (Basel) | 2022 | 36497321 | PubTator, text mining | PubMed |
| Wild-Type Isocitrate Dehydrogenase-Dependent Oxidative Decarboxylation and Reductive Carboxylation in Cancer and Their Clinical Significance. | Cancers (Basel) | 2022 | 36497259 | PubTator, text mining | PubMed |
| An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies. | Cell Mol Life Sci | 2022 | 36494469 | PubTator, text mining | PubMed |
| Leptin Promotes HTR-8/SVneo Cell Invasion via the Crosstalk between MTA1/WNT and PI3K/AKT Pathways. | Dis Markers | 2022 | 36457544 | PubTator, text mining | PubMed |
| Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification. | EBioMedicine | 2022 | 36442320 | PubTator, text mining | PubMed |
| SILAC-based quantitative proteomics and microscopy analysis of cancer cells treated with the N-glycolyl GM3-specific anti-tumor antibody 14F7. | Front Immunol | 2022 | 36439103 | PubTator, text mining | PubMed |
| The single-cell expression profile of transposable elements and transcription factors in human early biparental and uniparental embryonic development. | Front Cell Dev Biol | 2022 | 36438554 | PubTator, text mining | PubMed |
| The Emerging Role of Chromatin Remodeling Complexes in Ovarian Cancer. | Int J Mol Sci | 2022 | 36430148 | PubTator, text mining | PubMed |
| Metformin Suppresses Hepatocellular Carcinoma through Regulating Alternative Splicing of LGR4. | J Oncol | 2022 | 36385965 | PubTator, text mining | PubMed |
| Role of SALL4 in HER2+ Breast Cancer Progression: Regulating PI3K/AKT Pathway. | Int J Mol Sci | 2022 | 36362083 | PubTator, text mining | PubMed |
| Curcumin and Its Analogs in Non-Small Cell Lung Cancer Treatment: Challenges and Expectations. | Biomolecules | 2022 | 36358986 | PubTator, text mining | PubMed |
| Guava Leaf Essential Oil as a Potent Antioxidant and Anticancer Agent: Validated through Experimental and Computational Study. | Antioxidants (Basel) | 2022 | 36358576 | PubTator, text mining | PubMed |
| Recent Advances on DNA Base Flipping: A General Mechanism for Writing, Reading, and Erasing DNA Modifications. | Adv Exp Med Biol | 2022 | 36350515 | PubTator, text mining | PubMed |
| Epigenome-wide DNA methylation analysis of whole blood cells derived from patients with GAD and OCD in the Chinese Han population. | Transl Psychiatry | 2022 | 36344488 | PubTator, text mining | PubMed |
| Hypoxia-inducible factor 1-alpha is a driving mechanism linking chronic obstructive pulmonary disease to lung cancer. | Front Oncol | 2022 | 36338690 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9112/papers?page=14